Literature DB >> 3002616

Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1.

O Nilsson, F T Brezicka, J Holmgren, S Sörenson, L Svennerholm, F Yngvason, L Lindholm.   

Abstract

Monoclonal antibodies with an apparent specificity for fucosyl-GM1 (Fuc-GM1) were produced by the immunization of mice with Fuc-GM1 adsorbed to Salmonella minnesota bacteria and fusion of the spleen cells with the myeloma cell line Sp 2/0. The antibodies detected Fuc-GM1 with a unique ceramide composition containing 2-hydroxy fatty acids in 11 of 12 cases of small cell carcinoma of the lung. Trace amounts of Fuc-GM1 were detected in 1 of 11 squamous epithelial cell lung carcinomas. Fuc-GM1 was also detected in 1 of 7 pancreas carcinomas but was not detected in any of the other cancers analyzed. Small amounts of Fuc-GM1 without 2-hydroxy fatty acids were detected in normal adult pancreas, spleen, and brain but could not be detected in normal lung tissue. Fuc-GM1 with 2-hydroxy fatty acids is suggested to be a specific ganglioside associated with small cell lung carcinomas. The monoclonal antibodies directed against Fuc-GM1 may be useful for specific immunodiagnosis of small cell lung carcinomas and might also be useful for specific immunotherapy of these malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3002616

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay.

Authors:  T Pallesen; A Vangsted; L Drivsholm; H Clausen; J Zeuthen; H Wallin
Journal:  Glycoconj J       Date:  1992-12       Impact factor: 2.916

Review 2.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Authors:  Hiroko Hama
Journal:  Biochim Biophys Acta       Date:  2009-12-21

3.  Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker.

Authors:  Qinying Li; Mei Sun; Mingsheng Yu; Qianyun Fu; Hao Jiang; Guangli Yu; Guoyun Li
Journal:  Glycoconj J       Date:  2019-07-11       Impact factor: 2.916

4.  A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer.

Authors:  Paul Ponath; Daniel Menezes; Chin Pan; Bing Chen; Miho Oyasu; Debbie Strachan; Heidi LeBlanc; Huadong Sun; Xi-Tao Wang; Vangipuram S Rangan; Shrikant Deshpande; Sandra Cristea; Kwon-Sik Park; Julien Sage; Pina M Cardarelli
Journal:  Clin Cancer Res       Date:  2018-07-18       Impact factor: 12.531

5.  Recent Development in Carbohydrate Based Anti-cancer Vaccines.

Authors:  Zhaojun Yin; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2012-02-29       Impact factor: 1.667

6.  Tetanus toxin as a marker for small-cell lung cancer cell lines.

Authors:  J Heymanns; K Neumann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells.

Authors:  Nathan L Alderson; Hiroko Hama
Journal:  J Lipid Res       Date:  2009-01-22       Impact factor: 5.922

Review 8.  Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database.

Authors:  Eric Sterner; Natalie Flanagan; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2016-05-25       Impact factor: 5.100

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.